You may have heard about a new medication that was recently FDA approved for cutaneous squamous cell carcinoma (CSCC). Libtayo (cemiplimab-rwlc) is a type of immunotherapy called a checkpoint blockade inhibitor, and it’s the first one approved to treat certain cases of CSCC. This is exciting news, so let’s break down how this new drug works and whom it might help.
Squamous Cell Carcinoma
Your eyes can focus on a tiny splinter in the finger of a squirming child, a stop sign in the distance or stars blinking light-years away. You can roll your eyes, flirt with them, do a double-take and express joy or despair without words. When you think about how amazing your eyes are, wouldn’t you do anything to protect them?
Early detection of skin cancer can save your skin and, in some cases, even your life. Watch for these clues, and if something doesn’t heal, is growing or just doesn’t seem right, see a dermatologist right away.
Both a precancer and an atypical mole may look unusual, but each has unique characteristics. An expert explains the differences.
I recently had a skin cancer removed, and I’m worried about recurrence. I know I’m now at higher risk for more skin cancers, but can that same cancer come back even after it’s been treated?
Even with my background in beauty and skin health, words like dysplastic nevus and metastatic are not words I have used every day and can be worrisome when you hear them used in your dermatologist’s office. So, for my first blog post, I thought I’d share some of my recently acquired knowledge with our readers.
My father was diagnosed with a small squamous cell carcinoma on his ear. He says it’s nothing and refuses to go back and have it removed. What can I do to convince him he’ll be better off with treatment?